AbbVie Inc shows prevailing Real Value of $86.6941 per share. The current price of the firm is $93.6. At this time the firm appears to be over valued. Macroaxis approximates value of AbbVie Inc from analyzing the firm fundamentals such as Profit Margin of
24.77% and Return On Equity of 113.57% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Valuation Drivers Correlation
|Investment Horizon||30 Days Login to change|
AbbVie Inc is number one stock in price to book category among related companies. It is rated second in beta category among related companies totaling about 0.06 of Beta per Price to Book. The ratio of Price to Book to Beta for AbbVie Inc is roughly 17.49
AbbVie is not too risky asset. Calculation of real value of AbbVie Inc is based on 1 month time horizon. Increasing AbbVie Inc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.